Welcome! Get free delivery from €130+ orders En Savoir Plus

BPC 10mg + TB 10mg

$ 178

Buy the high-strength BPC-157 10mg + TB-500 10mg blend, a potent research peptide combination (often referred to as the “Wolverine Stack”) designed for advanced tissue repair and accelerated recovery. BPC-157 supports localized healing of tendons, ligaments, muscles, joints, and gut integrity, while TB-500 delivers systemic benefits through enhanced cell migration, angiogenesis, reduced inflammation, and improved tissue flexibility—ideal for serious injury rehabilitation, post-surgical recovery, chronic tendon/muscle issues, and comprehensive regenerative protocols. Investigational only—not FDA-approved for human use.

-
+
Ajouter à la liste d'Envies
Ajouter à la liste d'Envies

Description

The BPC-157 10mg + TB-500 10mg blend combines two leading regenerative peptides in a high-potency 20mg total vial, offering amplified and synergistic effects for tissue repair, inflammation reduction, and recovery acceleration. BPC-157 (Body Protection Compound-157), a synthetic 15-amino acid peptide derived from a gastric protective protein, excels at localized tissue regeneration by upregulating growth factors, enhancing collagen deposition and organization, protecting endothelial cells, promoting angiogenesis, suppressing inflammation, and accelerating healing of tendons, ligaments, muscles, cartilage, bones, nerves, and gastrointestinal structures (with well-documented gut-protective, anti-ulcer, and mucosal repair properties). TB-500 (Thymosin Beta-4 or its active fragment) provides broader systemic support by regulating actin dynamics to facilitate cell migration and proliferation, stimulating new blood vessel formation, decreasing excessive fibrosis/scar tissue, lowering inflammation, and improving overall tissue flexibility, endurance, and resilience across muscles, skin, cardiac tissue, and other systems. Together, this higher-dose stack is extensively discussed in athletic recovery, bodybuilding, regenerative medicine, and chronic injury communities for its potential to deliver faster resolution of acute and chronic injuries (strains, sprains, partial/full tears, tendon/ligament damage), significantly shortened downtime after surgery or intense training, reduced chronic pain and inflammation, minimized scar formation, enhanced joint stability and range of motion, improved muscle and tendon integrity, and support for degenerative or inflammatory conditions when combined with proper rehabilitation, nutrition, and rest. Typical research protocols involve reconstituting the 20mg vial with bacteriostatic water (or acetic acid water for certain peptides) and administering via subcutaneous or intramuscular injection—common approaches include 250–750 mcg BPC-157 daily (often localized near the injury site) + 4–10 mg TB-500 1–2 times weekly for systemic effects, with cycles usually lasting 4–8 weeks followed by equal time off to prevent potential tolerance or diminishing returns. Many users report substantial reductions in pain, improved mobility, and functional recovery within 1–6 weeks when paired with progressive loading, physical therapy, and optimal recovery practices. While preclinical animal studies and extensive anecdotal/user evidence support accelerated tendon/ligament/muscle healing, anti-inflammatory actions, and tissue regeneration, the BPC-157 + TB-500 combination is not FDA-approved for any therapeutic, injury recovery, performance enhancement, or medical use as of 2026—no large-scale, randomized controlled human trials exist to confirm long-term efficacy, optimal dosing, or safety. Evidence is primarily derived from animal/preclinical research, small observational reports, and widespread user experiences rather than rigorous clinical validation. Reported side effects are generally mild (injection-site irritation, temporary fatigue, headaches, nausea, or localized swelling), but unknowns remain regarding potential immunogenicity, long-term risks (e.g., abnormal cell growth promotion in certain models), interactions, or variability from unregulated sources. Both peptides are prohibited by WADA for athletes and face regulatory restrictions in many regions. Never use this high-potency blend without supervision from a qualified healthcare provider experienced in peptide therapies, as self-administration carries risks of contamination, improper reconstitution/dosing, adverse reactions, or legal issues. Prioritize evidence-based recovery strategies—physical therapy, nutrition, rest, and approved treatments—for injuries or inflammation. Consult a professional to assess suitability, source from reputable compounding pharmacies if considered under guidance, and stay informed on emerging research or regulatory developments. BPC-157 10mg + TB-500 10mg is not a substitute for proven medical interventions or rehabilitation protocols.

Des informations supplémentaires

DOSE

BB20 20mg(10vials)